Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.

TitleDietary lycopene intake and risk of prostate cancer defined by ERG protein expression.
Publication TypeJournal Article
Year of Publication2016
AuthorsGraff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA
JournalAm J Clin Nutr
Volume103
Issue3
Pagination851-60
Date Published2016 Mar
ISSN1938-3207
KeywordsAdult, Antineoplastic Agents, Phytogenic, Antioxidants, Carotenoids, Diet, Feeding Behavior, Humans, Lycopene, Lycopersicon esculentum, Male, Middle Aged, Oncogene Proteins, Fusion, Plant Extracts, Prostatic Neoplasms, Trans-Activators, Transcriptional Regulator ERG
Abstract

BACKGROUND: There is limited evidence that supports etiologically distinct molecular subtypes of prostate cancer, the identification of which may improve prevention. Given their antioxidant properties, we hypothesized that lycopene and tomato sauce may be especially protective against diseases harboring the common gene fusion transmembrane protease, serine 2 (TMPRSS2):v-ets avian erythroblastosis virus E26 oncogene homolog (ERG).

OBJECTIVE: We aimed to examine associations between estimated lycopene and tomato sauce intake and the risk of prostate cancer defined by ERG protein expression subtype.

DESIGN: Our study population consisted of a prospective cohort of 46,719 men from the Health Professionals Follow-Up Study. TMPRSS2:ERG was assessed by ERG immunohistochemistry on tumor tissue microarrays constructed from radical prostatectomy specimens. We used multivariable competing risk models to calculate HRs and 95% CIs for the risk of ERG-positive and, separately, ERG-negative disease. We implemented inverse probability weighting to account for evaluating ERG status only in surgically treated cases.

RESULTS: During 23 y of follow-up, 5543 men were diagnosed with prostate cancer, among whom 884 were assayed for ERG (426 ERG-positive). With inclusion of only the latter cases, increasing cumulative average tomato sauce intake was associated with a decreased risk of prostate cancer overall (≥2 servings/wk compared with <1 serving/mo; multivariable HR: 0.70; 95% CI: 0.52, 0.95; P-trend = 0.002). With respect to molecular subtypes, cumulative average tomato sauce intake was associated with a decreased risk of ERG-positive disease (HR: 0.54; 95% CI: 0.37, 0.81; P-trend = 0.004) but not with ERG-negative disease (HR: 0.96; 95% CI: 0.62, 1.50; P-trend = 0.10) (P-heterogeneity = 0.04). Increasing quintiles of lycopene intake were associated with a decreased risk of both subtypes (P-heterogeneity = 0.79). Inverse probability weighting did not materially change the results.

CONCLUSIONS: Our results lend some support to the hypothesis that prostate cancers that harbor TMPRSS2:ERG may be etiologically distinct from fusion-negative cancers. In particular, tomato sauce consumption may play a role in reducing TMPRSS2:ERG-positive disease.

DOI10.3945/ajcn.115.118703
Alternate JournalAm J Clin Nutr
PubMed ID26817504
PubMed Central IDPMC4763492
Grant ListP50 CA090381 / CA / NCI NIH HHS / United States
CA136578 / CA / NCI NIH HHS / United States
R25 CA098566 / CA / NCI NIH HHS / United States
CA141298 / CA / NCI NIH HHS / United States
R25 CA112355 / CA / NCI NIH HHS / United States
UM1CA167552 / CA / NCI NIH HHS / United States
5P50CA090381 / CA / NCI NIH HHS / United States
CA097193 / CA / NCI NIH HHS / United States
T32 CA09001 / CA / NCI NIH HHS / United States
T32 CA009001 / CA / NCI NIH HHS / United States
P01 CA055075 / CA / NCI NIH HHS / United States
U01CA098233 / CA / NCI NIH HHS / United States
CA40360 / CA / NCI NIH HHS / United States
Related Faculty: 
Massimo Loda, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700